A Comparison of Aztreonam and Two Regimens of Gentamicin in a Rabbit Model of Intra-Amniotic Infection and Sepsis

Abstract

Objective: To compare aztreonam in a standard dose with two gentamicin doses in the early treatment of experimental intra-amniotic infection in rabbits induced by intracervical inoculation with Escherichia coli.

Methods: Timed pregnant rabbits on day 21 (70% of gestation) were inoculated intracervically with 10⁴-10⁵ colony-forming units of E coli. After inoculation, the animals were treated with one of three regimens: 1) aztreonam at 90 mg/kg/day (“standard” dose in humans), 2) gentamicin at 4.5 mg/kg/day (“standard” dose in humans), or 3) higher-dose gentamicin at 6.0 mg/kg/day, each given in three divided doses daily. Outcomes included fever, delivery, and presence of a live fetus. At necropsy, cultures were taken from endometrium, amniotic fluid, and blood. Data were analyzed by Fisher exact test because the expected cell size was fewer than five.

Results: Compared with rabbits treated with aztreonam, those treated with gentamicin 4.5 mg/kg/day delivered significantly more often (P = .002), had more positive cultures (P < .001), and had significantly fewer live fetuses (P < .001). Compared with rabbits treated with gentamicin 6.0 mg/kg/day, those treated with gentamicin 4.5 mg/kg/day delivered more often (P = .003), had fewer live fetuses (P = .02), and had more positive cultures (P = .02). There were no significant differences between the aztreonam and gentamicin 6.0 mg/kg/day groups.

Conclusions: This study demonstrates in an animal model that aztreonam and gentamicin at 6.0 mg/kg/day are more effective than gentamicin at 4.5 mg/kg/day (a dose that is widely used empirically in humans) in the early treatment of experimental intra-amniotic infection in rabbits. Aztreonam was as effective as gentamicin at 6.0 mg/kg/day. In this rabbit model, in which intra-amniotic infection is accompanied by maternal sepsis, 4.5 mg/kg/day of gentamicin was not adequate for the treatment of severe maternal infection.

Keywords

Intra-amniotic infection animal model pregnancy gentamicin aztreonam

Get full access to this article

View all access options for this article.

References

1. Gibbs RS , Duff P . Progress in pathogenesis and management of clinical inta-amniotic infection. Am J Obstet Gynecol 1991;164:1317-1326.

2. Duff P , Jorgensen JH , Gibbs RS , Blanco JD , Alexander G , Castaneda YS . Serum gentamicin levels in patients with post-cesarean endomyometritis. Obstet Gynecol 1983;61:723-727.

3. Zaske DE , Cipolle RJ , Strate RG , Malo JW , Koszalka MF . Rapid gentamicin elimination in obstetric patients. Obstet Gynecol 1980;56:559-564.

4. McDuffie RS , Blanton SJ , Shikes RH , Gibbs RS . A rabbit model for bacterially induced preterm pregnancy loss: Intervention studies with ampicillin-sulbactam. Am J Obstet Gynecol 1991;165:1568-1574.

5. McDuffie RS , Sherman MP , Gibbs RS . Amniotic fluid tumor necrosis factor-α and interleukin-1 in a rabbit model of bacterially-induced preterm pregnancy loss. Am J Obstet Gynecol 1992;167:1583-1588.

6. Heddleston L , McDuffie RS , Gibbs RS . A rabbit model for ascending infection in pregnancy: Intervention with indomethacin and delayed ampicillin-sulbactam therapy. Am J Obstet Gynecol 1993;169:708-712.

7. Weinstein AJ , Gibbs RS , Gallagher M . Placental transfer of clindamycin and gentamicin in term pregnancy. Am J Obstet Gynecol 1976;124:688-691.

8. Lazebnik N , Noy S , Lazebnik R , Hezroni Y , Amoday I , Aviram A . Gentamicin serum half-life: A comparison between pregnant and non-pregnant women. Postgrad Med J 1985;61:979-981.

9. Gibbs RS , Dinsmoor MJ , Newton ER , Ramamurthy RS . A randomized trial of intrapartum versus immediate post-partum treatment of women with intra-amniotic infection. Obstet Gynecol 1988;72:823-828.